INVIVO THERAPEUTICS HOLDINGS CORP. Restructuring Costs
INVIVO THERAPEUTICS HOLDINGS CORP. reported Restructuring Costs of $0 for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2019-04-01
- INVIVO THERAPEUTICS HOLDINGS CORP. restructuring costs for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- INVIVO THERAPEUTICS HOLDINGS CORP. restructuring costs for the quarter ending 2018-06-30 was $98.00K.
- INVIVO THERAPEUTICS HOLDINGS CORP. restructuring costs for the quarter ending 2018-03-31 was $196.00K.
- INVIVO THERAPEUTICS HOLDINGS CORP. restructuring costs for the quarter ending 2017-12-31 was $160.00K.
- INVIVO THERAPEUTICS HOLDINGS CORP. restructuring costs for fiscal 2017 was $898.00K.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-08 | $98.00K derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | $454.00K derived: sum of 4 quarters · filed 2019-04-01 |
| 2018-06-30 | $98.00K 10-Q · filed 2018-08-07 | $294.00K 10-Q · filed 2018-08-07 | $454.00K derived: sum of 3 quarters · filed 2019-04-01 | $1.19M derived: sum of 4 quarters · filed 2019-04-01 |
| 2018-03-31 | $196.00K 10-Q · filed 2018-05-07 | $356.00K derived: sum of 2 quarters · filed 2019-04-01 | $1.09M derived: sum of 3 quarters · filed 2019-04-01 | |
| 2017-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $898.00K derived: sum of 2 quarters · filed 2019-04-01 | $898.00K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $738.00K 10-Q · filed 2018-11-08 | $738.00K 10-Q · filed 2018-11-08 |